Table 4 Endosialin expression in tumour cells in relation to clinicopathological and biological variables in rectal cancer patients
Variables | Non-Radiotherapy | p-value | Radiotherapy | p-value | ||
|---|---|---|---|---|---|---|
| Â | Negative (%) | Positive (%) | Â | Negative (%) | Positive (%) | Â |
Growth pattern | Â | Â | 0.01 | Â | Â | 0.06 |
   Expansive | 35 (71) | 14 (29) |  | 21 (75) | 7 (25) |  |
   Infiltrative | 7 (39) | 11 (61) |  | 12 (50) | 12 (50) |  |
Cox-2 | Â | Â | 0.16 | Â | Â | 0.10 |
   Weak | 22 (58) | 16 (42) |  | 20 (77) | 6 (23) |  |
   Strong | 25 (74) | 9 (26) |  | 18 (56) | 14 (44) |  |
p73 | Â | Â | 0.01 | Â | Â | 0.44 |
   Weak | 23 (82) | 5 (18) |  | 14 (70) | 6 (30) |  |
   Strong | 23 (53) | 20 (47) |  | 19 (59) | 13 (41) |  |
PRL | Â | Â | 0.25 | Â | Â | 0.02 |
   Weak | 14 (74) | 5 (26) |  | 16 (84) | 3 (16) |  |
   Strong | 27 (59) | 19 (41) |  | 18 (53) | 16 (47) |  |